191 related articles for article (PubMed ID: 3005824)
1. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
Cooper DM; Bier-Laning CM; Halford MK; Ahlijanian MK; Zahniser NR
Mol Pharmacol; 1986 Feb; 29(2):113-9. PubMed ID: 3005824
[TBL] [Abstract][Full Text] [Related]
2. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
3. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
Roseboom PH; Gnegy ME
Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
[TBL] [Abstract][Full Text] [Related]
4. Evidence that the D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland is associated with an inhibitory guanyl nucleotide component.
Cote TE; Frey EA; Grewe CW; Kebabian JW
J Neural Transm Suppl; 1983; 18():139-47. PubMed ID: 6308147
[TBL] [Abstract][Full Text] [Related]
5. Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by D-1 dopamine receptors, guanine nucleotides, and sodium fluoride.
Battaglia G; Norman AB; Hess EJ; Creese I
J Neurochem; 1986 Apr; 46(4):1180-5. PubMed ID: 3005508
[TBL] [Abstract][Full Text] [Related]
6. Characterization of D-2 dopamine receptors in a tumor of the rat anterior pituitary gland.
Lin C; McGonigle P; Molinoff PB
J Pharmacol Exp Ther; 1987 Sep; 242(3):950-6. PubMed ID: 2958621
[TBL] [Abstract][Full Text] [Related]
7. D-2 dopamine receptor-mediated inhibition of adenylate cyclase activity in the intermediate lobe of the rat pituitary gland requires guanosine 5'-triphosphate.
Cote TE; Grewe CW; Tsuruta K; Stoof JC; Eskay RL; Kebabian JW
Endocrinology; 1982 Mar; 110(3):812-9. PubMed ID: 7056233
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of l-stepholidine on D2 receptor-mediated inhibition of synaptosomal adenylate cyclase in rat corpus striatum.
Hu G; Hu Y; Jin GZ
Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):104-10. PubMed ID: 1598823
[TBL] [Abstract][Full Text] [Related]
9. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors.
Schoffelmeer AN; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1988 May; 245(2):658-63. PubMed ID: 2452877
[TBL] [Abstract][Full Text] [Related]
10. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.
Weiss S; Sebben M; Garcia-Sainz JA; Bockaert J
Mol Pharmacol; 1985 Jun; 27(6):595-9. PubMed ID: 2987658
[TBL] [Abstract][Full Text] [Related]
11. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
12. Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration.
Barnett JV; Kuczenski R
J Pharmacol Exp Ther; 1986 Jun; 237(3):820-5. PubMed ID: 2940359
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
14. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
Hess EJ; Battaglia G; Norman AB; Creese I
Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
[TBL] [Abstract][Full Text] [Related]
15. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.
Gnegy ME; Bernabei A; Treisman G
J Pharmacol Exp Ther; 1983 Mar; 224(3):627-33. PubMed ID: 6827485
[TBL] [Abstract][Full Text] [Related]
16. Comparison of inhibitory actions of chlorpromazine or its 7,8-dihydroxy and 7,8-dioxo-didesmethyl analogs on DA-sensitive adenylate cyclase and calmodulin activation of phosphodiesterase in rat striatum.
Palmer GC; Pajer KA; Manian AA
Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):202-11. PubMed ID: 2988471
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of rat retinal dopamine receptors.
Qu ZX; Fertel R; Neff NH; Hadjiconstantinou M
J Pharmacol Exp Ther; 1989 Feb; 248(2):621-5. PubMed ID: 2493095
[TBL] [Abstract][Full Text] [Related]
18. D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo.
Saller CF; Salama AI
J Pharmacol Exp Ther; 1986 Mar; 236(3):714-20. PubMed ID: 3005552
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
Enjalbert A; Bockaert J
Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
[TBL] [Abstract][Full Text] [Related]
20. Role of calmodulin-dependent phosphorylation in chronic sulpiride-induced striatal dopamine receptor supersensitivity.
Lau YS; Runice C; Dowd F
J Pharmacol Exp Ther; 1984 Apr; 229(1):32-7. PubMed ID: 6323689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
